SPONSOR
Ciusss de L'Est de l'Île de Montréal
Total Trials
3
Recruiting
3
Phases
Phase 1, Phase 2
Conditions studied: Hypnosis, Chronic Pain ManagementAcute Leukemia, High RiskMyelodysplastic Syndromes, High RiskHematologic Malignancy Requiring an Allogeneic Hematopoietic Stem Cell Transplant Lacking a DonorAcute Post Operative PainLaparotomyEpidural Analgesia
Ciusss de L'Est de l'Île de Montréal is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Hypnosis, Chronic Pain Management, Acute Leukemia, High Risk, Myelodysplastic Syndromes, High Risk, Hematologic Malignancy Requiring an Allogeneic Hematopoietic Stem Cell Transplant Lacking a Donor.
The trial portfolio spans Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Ciusss de L'Est de l'Île de Montréal
How many clinical trials has Ciusss de L'Est de l'Île de Montréal sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by Ciusss de L'Est de l'Île de Montréal, of which 3 are actively recruiting participants. These trials cover conditions including Hypnosis, Chronic Pain Management, Acute Leukemia, High Risk, Myelodysplastic Syndromes, High Risk. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Ciusss de L'Est de l'Île de Montréal research focus on?
Ciusss de L'Est de l'Île de Montréal clinical trials span Hypnosis, Chronic Pain Management, Acute Leukemia, High Risk, Myelodysplastic Syndromes, High Risk, Hematologic Malignancy Requiring an Allogeneic Hematopoietic Stem Cell Transplant Lacking a Donor, Acute Post Operative Pain, and additional conditions. The research pipeline includes Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Ciusss de L'Est de l'Île de Montréal clinical trial?
To participate in a Ciusss de L'Est de l'Île de Montréal trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Ciusss de L'Est de l'Île de Montréal trials with current recruitment status updated daily.
Clinical Trials by Ciusss de L'Est de l'Île de Montréal
NCT06279650
Recruiting
Self-hypnosis Training for Chronic Pain Management
Hypnosis, Chronic Pain Management
NCT07301866 Phase 1, Phase 2
Recruiting
A Study Testing an Improved Dose of UM171 to Help Make Cord Blood Transplants More Effective and Safe.
Acute Leukemia, High Risk
NCT05534945
Recruiting
PIB for Post-operative Analgesia After Laparotomy : Determining the Optimum Dose
Acute Post Operative Pain
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology